Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways

被引：30

作者：

Candotti, F

Notarangelo, L

Visconti, R

O'Shea, J

机构：

[1] Natl Inst Arthritis & Musculoskeletal & Skin Dis, Mol Immunol & Inflammat Branch, Bethesda, MD 20892 USA

[2] Natl Human Genome Res Inst, Genet & Mol Biol Branch, NIH, Bethesda, MD USA

[3] Univ Brescia, Dept Pediat, Brescia, Italy

[4] Univ Frederico 2, Dept Pathol, Naples, Italy

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2002年 / 109卷 / 10期

关键词：

D O I：

10.1172/JCI200215769

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：1261 / 1269

页数：9

共 64 条

[1] An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains [J].

Aaltonen, J ;

Bjorses, P ;

Perheentupa, J ;

HorelliKuitunen, N ;

Palotie, A ;

Peltonen, L ;

Lee, YS ;

Francis, F ;

Hennig, S ;

Thiel, C ;

Lehrach, H ;

Yaspo, ML .

NATURE GENETICS, 1997, 17 (04) :399-403

[2] Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome [J].

Ariga, T ;

Kondoh, T ;

Yamaguchi, K ;

Yamada, M ;

Sasaki, S ;

Nelson, DL ;

Ikeda, H ;

Kobayashi, K ;

Moriuchi, H ;

Sakiyama, Y .

JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :5245-5249

[3] Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy [J].

Arredondo-Vega, FX ;

Santisteban, I ;

Richard, E ;

Bali, P ;

Koleilat, M ;

Loubser, M ;

Al-Ghonaium, A ;

Al-Helali, M ;

Hershfield, MS .

BLOOD, 2002, 99 (03) :1005-1013

[4]

Bauer TR, 2000, CURR OPIN MOL THER, V2, P383

[5] GENE-THERAPY IN PERIPHERAL-BLOOD LYMPHOCYTES AND BONE-MARROW FOR ADA(-) IMMUNODEFICIENT PATIENTS [J].

BORDIGNON, C ;

NOTARANGELO, LD ;

NOBILI, N ;

FERRARI, G ;

CASORATI, G ;

PANINA, P ;

MAZZOLARI, E ;

MAGGIONI, D ;

ROSSI, C ;

SERVIDA, P ;

UGAZIO, AG ;

MAVILIO, F .

SCIENCE, 1995, 270 (5235) :470-475

[6] Primary immunodeficiency diseases due to defects in lymphocytes. [J].

Buckley, RH .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (18) :1313-1324

[7] Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].

Cavazzana-Calvo, M ;

Hacein-Bey, S ;

Basile, CD ;

Gross, F ;

Yvon, E ;

Nusbaum, P ;

Selz, F ;

Hue, C ;

Certain, S ;

Casanova, JL ;

Bousso, P ;

Le Deist, F ;

Fischer, A .

SCIENCE, 2000, 288 (5466) :669-672

[8] Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains [J].

Chen, M ;

Cheng, A ;

Candotti, F ;

Zhou, YJ ;

Hymel, A ;

Fasth, A ;

Notarangelo, LD ;

O'Shea, JJ .

MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (03) :947-956

[9] ISOLATION OF A NOVEL GENE MUTATED IN WISKOTT-ALDRICH SYNDROME [J].

DERRY, JMJ ;

OCHS, HD ;

FRANCKE, U .

CELL, 1994, 78 (04) :635-644

[10] Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia [J].

Devriendt, K ;

Kim, AS ;

Mathijs, G ;

Frints, SGM ;

Schwartz, M ;

Van den Oord, JJ ;

Verhoef, GEG ;

Boogaerts, MA ;

Fryns, JP ;

You, DQ ;

Rosen, MK ;

Vandenberghe, P .

NATURE GENETICS, 2001, 27 (03) :313-317

← 1 2 3 4 5 6 7 →